TY  - GEN
AU  - Long,Georgina V
AU  - Saw,Robyn P M
AU  - Lo,Serigne
AU  - Nieweg,Omgo E
AU  - Shannon,Kerwin F
AU  - Gonzalez,Maria
AU  - Guminski,Alexander
AU  - Lee,Jenny H
AU  - Lee,Hansol
AU  - Ferguson,Peter M
AU  - Rawson,Robert V
AU  - Wilmott,James S
AU  - Thompson,John F
AU  - Kefford,Richard F
AU  - Ch'ng,Sydney
AU  - Stretch,Jonathan R
AU  - Emmett,Louise
AU  - Kapoor,Rony
AU  - Rizos,Helen
AU  - Spillane,Andrew J
AU  - Scolyer,Richard A
AU  - Menzies,Alexander M
TI  - Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAF
SN  - 1474-5488
PY  - 2020///0622
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Mutation
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Oximes
KW  - Proto-Oncogene Proteins B-raf
KW  - genetics
KW  - Pyridones
KW  - Pyrimidinones
KW  - Skin Neoplasms
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(19)30331-6
ER  -